Gene name:
PPARA (NR1C1;PPAR) ;
Protein name:
Peroxisome proliferator-activated receptor alpha (PPAR-alpha) ;
Alternative:
Nuclear receptor subfamily 1 group C member 1 ;
Organism:
Human (Homo sapiens).
General Annotation
Sub Unit:
Heterodimer; with RXRA. This heterodimerization is required for DNA binding and transactivation activity. Interacts with AKAP13, LPIN1 and PRDM16. Also interacts with PPARBP coactivator in vitro. Interacts with CITED2; the interaction stimulates its transcriptional activity (By similarity). Interacts with NCOA3 and NCOA6 coactivators.
Function:
Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety (By similarity). Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2.
Subcellular Location:
Nucleus
Protein Attributes:
50:
MVDTESPLCP | LSPLEAGDLE | SPLSEEFLQE | MGNIQEISQS | IGEDSSGSFG |
100:
FTEYQYLGSC | PGSDGSVITD | TLSPASSPSS | VTYPVVPGSV | DESPSGALNI |
150:
ECRICGDKAS | GYHYGVHACE | GCKGFFRRTI | RLKLVYDKCD | RSCKIQKKNR |
200:
NKCQYCRFHK | CLSVGMSHNA | IRFGRMPRSE | KAKLKAEILT | CEHDIEDSET |
250:
ADLKSLAKRI | YEAYLKNFNM | NKVKARVILS | GKASNNPPFV | IHDMETLCMA |
300:
EKTLVAKLVA | NGIQNKEAEV | RIFHCCQCTS | VETVTELTEF | AKAIPGFANL |
350:
DLNDQVTLLK | YGVYEAIFAM | LSSVMNKDGM | LVAYGNGFIT | REFLKSLRKP |
400:
FCDIMEPKFD | FAMKFNALEL | DDSDISLFVA | AIICCGDRPG | LLNVGHIEKM |
450:
QEGIVHVLRL | HLQSNHPDDI | FLFPKLLQKM | ADLRQLVTEH | AQLVQIIKKT |
468:
ESDAALHPLL | QEIYRDMY
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Mouse
Dog
Human
Rat
ELISA Kit for Human PPAR-alpha
ELISA Kit for Human PPAR-alpha
ELISA Kit for Human PPAR-alpha
ELISA Kit for Human PPAR-alpha
CLIA Kit for Human PPAR-alpha
CLIA Kit for Human PPAR-alpha
CLIA Kit for Human PPAR-alpha
CLIA Kit for Human PPAR-alpha
Polyclonal Antibody for Human PPAR-alpha
Polyclonal Antibody for Human PPAR-alpha
Polyclonal Antibody for Human PPAR-alpha
Polyclonal Antibody for Human PPAR-alpha
Monoclonal Antibody for Human PPAR-alpha
Monoclonal Antibody for Human PPAR-alpha
Monoclonal Antibody for Human PPAR-alpha
Monoclonal Antibody for Human PPAR-alpha
Protein for Human PPAR-alpha
Protein for Human PPAR-alpha
Protein for Human PPAR-alpha
Protein for Human PPAR-alpha
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);FUNCTION;VARIANT VAL-268
tissue :
Liver .
2.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);TISSUE SPECIFICITY
tissue :
Liver .
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);TISSUE SPECIFICITY
4.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
5.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
6.
"A novel alternatively spliced peroxisome proliferator-activated receptor alpha."
Jiang Y.
,
Xie Z.
,
Liu H.
,
Liu M.
,
Liu F.
Submitted (2008-01) to the EMBL/GenBank/DDBJ databases
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)
7.
"A genome annotation-driven approach to cloning the human ORFeome."
Collins J.E.
,
Wright C.L.
,
Edwards C.A.
,
Davis M.P.
,
Grinham J.A.
,
Cole C.G.
,
Goward M.E.
,
Aguado B.
,
Mallya M.
,
Mokrab Y.
,
Huckle E.J.
,
Beare D.M.
,
Dunham I.
Genome Biol.5:R84.1-R84.11(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
8.
"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T.
,
Suzuki Y.
,
Nishikawa T.
,
Otsuki T.
,
Sugiyama T.
,
Irie R.
,
Wakamatsu A.
,
Hayashi K.
,
Sato H.
,
Nagai K.
,
Kimura K.
,
Makita H.
,
Sekine M.
,
Obayashi M.
,
Nishi T.
,
Shibahara T.
,
Tanaka T.
,
Ishii S.
,
Yamamoto J.
,
Saito K.
,
Kawai Y.
,
Isono Y.
,
Nakamura Y.
,
Nagahari K.
,
Murakami K.
,
Yasuda T.
,
Iwayanagi T.
,
Wagatsuma M.
,
Shiratori A.
,
Sudo H.
,
Hosoiri T.
,
Kaku Y.
,
Kodaira H.
,
Kondo H.
,
Sugawara M.
,
Takahashi M.
,
Kanda K.
,
Yokoi T.
,
Furuya T.
,
Kikkawa E.
,
Omura Y.
,
Abe K.
,
Kamihara K.
,
Katsuta N.
,
Sato K.
,
Tanikawa M.
,
Yamazaki M.
,
Ninomiya K.
,
Ishibashi T.
,
Yamashita H.
,
Murakawa K.
,
Fujimori K.
,
Tanai H.
,
Kimata M.
,
Watanabe M.
,
Hiraoka S.
,
Chiba Y.
,
Ishida S.
,
Ono Y.
,
Takiguchi S.
,
Watanabe S.
,
Yosida M.
,
Hotuta T.
,
Kusano J.
,
Kanehori K.
,
Takahashi-Fujii A.
,
Hara H.
,
Tanase T.-O.
,
Nomura Y.
,
Togiya S.
,
Komai F.
,
Hara R.
,
Takeuchi K.
,
Arita M.
,
Imose N.
,
Musashino K.
,
Yuuki H.
,
Oshima A.
,
Sasaki N.
,
Aotsuka S.
,
Yoshikawa Y.
,
Matsunawa H.
,
Ichihara T.
,
Shiohata N.
,
Sano S.
,
Moriya S.
,
Momiyama H.
,
Satoh N.
,
Takami S.
,
Terashima Y.
,
Suzuki O.
,
Nakagawa S.
,
Senoh A.
,
Mizoguchi H.
,
Goto Y.
,
Shimizu F.
,
Wakebe H.
,
Hishigaki H.
,
Watanabe T.
,
Sugiyama A.
,
Takemoto M.
,
Kawakami B.
,
Yamazaki M.
,
Watanabe K.
,
Kumagai A.
,
Itakura S.
,
Fukuzumi Y.
,
Fujimori Y.
,
Komiyama M.
,
Tashiro H.
,
Tanigami A.
,
Fujiwara T.
,
Ono T.
,
Yamada K.
,
Fujii Y.
,
Ozaki K.
,
Hirao M.
,
Ohmori Y.
,
Kawabata A.
,
Hikiji T.
,
Kobatake N.
,
Inagaki H.
,
Ikema Y.
,
Okamoto S.
,
Okitani R.
,
Kawakami T.
,
Noguchi S.
,
Itoh T.
,
Shigeta K.
,
Senba T.
,
Matsumura K.
,
Nakajima Y.
,
Mizuno T.
,
Morinaga M.
,
Sasaki M.
,
Togashi T.
,
Oyama M.
,
Hata H.
,
Watanabe M.
,
Komatsu T.
,
Mizushima-Sugano J.
,
Satoh T.
,
Shirai Y.
,
Takahashi Y.
,
Nakagawa K.
,
Okumura K.
,
Nagase T.
,
Nomura N.
,
Kikuchi H.
,
Masuho Y.
,
Yamashita R.
,
Nakai K.
,
Yada T.
,
Nakamura Y.
,
Ohara O.
,
Isogai T.
,
Sugano S.
more...
Nat. Genet.36:40-45(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
tissue :
Brain .
9.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
10.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANT VAL-162
11.
"The DNA sequence of human chromosome 22."
Dunham I.
,
Hunt A.R.
,
Collins J.E.
,
Bruskiewich R.
,
Beare D.M.
,
Clamp M.
,
Smink L.J.
,
Ainscough R.
,
Almeida J.P.
,
Babbage A.K.
,
Bagguley C.
,
Bailey J.
,
Barlow K.F.
,
Bates K.N.
,
Beasley O.P.
,
Bird C.P.
,
Blakey S.E.
,
Bridgeman A.M.
,
Buck D.
,
Burgess J.
,
Burrill W.D.
,
Burton J.
,
Carder C.
,
Carter N.P.
,
Chen Y.
,
Clark G.
,
Clegg S.M.
,
Cobley V.E.
,
Cole C.G.
,
Collier R.E.
,
Connor R.
,
Conroy D.
,
Corby N.R.
,
Coville G.J.
,
Cox A.V.
,
Davis J.
,
Dawson E.
,
Dhami P.D.
,
Dockree C.
,
Dodsworth S.J.
,
Durbin R.M.
,
Ellington A.G.
,
Evans K.L.
,
Fey J.M.
,
Fleming K.
,
French L.
,
Garner A.A.
,
Gilbert J.G.R.
,
Goward M.E.
,
Grafham D.V.
,
Griffiths M.N.D.
,
Hall C.
,
Hall R.E.
,
Hall-Tamlyn G.
,
Heathcott R.W.
,
Ho S.
,
Holmes S.
,
Hunt S.E.
,
Jones M.C.
,
Kershaw J.
,
Kimberley A.M.
,
King A.
,
Laird G.K.
,
Langford C.F.
,
Leversha M.A.
,
Lloyd C.
,
Lloyd D.M.
,
Martyn I.D.
,
Mashreghi-Mohammadi M.
,
Matthews L.H.
,
Mccann O.T.
,
Mcclay J.
,
Mclaren S.
,
McMurray A.A.
,
Milne S.A.
,
Mortimore B.J.
,
Odell C.N.
,
Pavitt R.
,
Pearce A.V.
,
Pearson D.
,
Phillimore B.J.C.T.
,
Phillips S.H.
,
Plumb R.W.
,
Ramsay H.
,
Ramsey Y.
,
Rogers L.
,
Ross M.T.
,
Scott C.E.
,
Sehra H.K.
,
Skuce C.D.
,
Smalley S.
,
Smith M.L.
,
Soderlund C.
,
Spragon L.
,
Steward C.A.
,
Sulston J.E.
,
Swann R.M.
,
Vaudin M.
,
Wall M.
,
Wallis J.M.
,
Whiteley M.N.
,
Willey D.L.
,
Williams L.
,
Williams S.A.
,
Williamson H.
,
Wilmer T.E.
,
Wilming L.
,
Wright C.L.
,
Hubbard T.
,
Bentley D.R.
,
Beck S.
,
Rogers J.
,
Shimizu N.
,
Minoshima S.
,
Kawasaki K.
,
Sasaki T.
,
Asakawa S.
,
Kudoh J.
,
Shintani A.
,
Shibuya K.
,
Yoshizaki Y.
,
Aoki N.
,
Mitsuyama S.
,
Roe B.A.
,
Chen F.
,
Chu L.
,
Crabtree J.
,
Deschamps S.
,
Do A.
,
Do T.
,
Dorman A.
,
Fang F.
,
Fu Y.
,
Hu P.
,
Hua A.
,
Kenton S.
,
Lai H.
,
Lao H.I.
,
Lewis J.
,
Lewis S.
,
Lin S.-P.
,
Loh P.
,
Malaj E.
,
Nguyen T.
,
Pan H.
,
Phan S.
,
Qi S.
,
Qian Y.
,
Ray L.
,
Ren Q.
,
Shaull S.
,
Sloan D.
,
Song L.
,
Wang Q.
,
Wang Y.
,
Wang Z.
,
White J.
,
Willingham D.
,
Wu H.
,
Yao Z.
,
Zhan M.
,
Zhang G.
,
Chissoe S.
,
Murray J.
,
Miller N.
,
Minx P.
,
Fulton R.
,
Johnson D.
,
Bemis G.
,
Bentley D.
,
Bradshaw H.
,
Bourne S.
,
Cordes M.
,
Du Z.
,
Fulton L.
,
Goela D.
,
Graves T.
,
Hawkins J.
,
Hinds K.
,
Kemp K.
,
Latreille P.
,
Layman D.
,
Ozersky P.
,
Rohlfing T.
,
Scheet P.
,
Walker C.
,
Wamsley A.
,
Wohldmann P.
,
Pepin K.
,
Nelson J.
,
Korf I.
,
Bedell J.A.
,
Hillier L.W.
,
Mardis E.
,
Waterston R.
,
Wilson R.
,
Emanuel B.S.
,
Shaikh T.
,
Kurahashi H.
,
Saitta S.
,
Budarf M.L.
,
McDermid H.E.
,
Johnson A.
,
Wong A.C.C.
,
Morrow B.E.
,
Edelmann L.
,
Kim U.J.
,
Shizuya H.
,
Simon M.I.
,
Dumanski J.P.
,
Peyrard M.
,
Kedra D.
,
Seroussi E.
,
Fransson I.
,
Tapia I.
,
Bruder C.E.
,
O'Brien K.P.
,
Wilkinson P.
,
Bodenteich A.
,
Hartman K.
,
Hu X.
,
Khan A.S.
,
Lane L.
,
Tilahun Y.
,
Wright H.
more...
Nature402:489-495(1999)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
12.
Mural R.J.
,
Istrail S.
,
Sutton G.G.
,
Florea L.
,
Halpern A.L.
,
Mobarry C.M.
,
Lippert R.
,
Walenz B.
,
Shatkay H.
,
Dew I.
,
Miller J.R.
,
Flanigan M.J.
,
Edwards N.J.
,
Bolanos R.
,
Fasulo D.
,
Halldorsson B.V.
,
Hannenhalli S.
,
Turner R.
,
Yooseph S.
,
Lu F.
,
Nusskern D.R.
,
Shue B.C.
,
Zheng X.H.
,
Zhong F.
,
Delcher A.L.
,
Huson D.H.
,
Kravitz S.A.
,
Mouchard L.
,
Reinert K.
,
Remington K.A.
,
Clark A.G.
,
Waterman M.S.
,
Eichler E.E.
,
Adams M.D.
,
Hunkapiller M.W.
,
Myers E.W.
,
Venter J.C.
more...
Submitted (2005-07) to the EMBL/GenBank/DDBJ databases
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
13.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : HETERODIMERIZATION WITH RXRA;FUNCTION;MUTAGENESIS OF CYS-122; LEU-422 AND LEU-433
14.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INTERACTION WITH NCOA3
15.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION
16.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : HETERODIMERIZATION WITH RXRA;FUNCTION;MUTAGENESIS OF ASP-304; LEU-370; LEU-391 AND ALA-431
17.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INTERACTION WITH NCOA6
18.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : HETERODIMERIZATION WITH RXRA
19.
"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha."
Fu J.
,
Gaetani S.
,
Oveisi F.
,
Lo Verme J.
,
Serrano A.
,
Rodriguez De Fonseca F.
,
Rosengarth A.
,
Luecke H.
,
Di Giacomo B.
,
Tarzia G.
,
Piomelli D.
Nature425:90-93(2003)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : IDENTIFICATION AS RECEPTOR FOR OLEYLETHANOLAMIDE
20.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INTERACTION WITH ASXL1 AND ASXL2
21.
"Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors."
Xu H.E.
,
Lambert M.H.
,
Montana V.G.
,
Plunket K.D.
,
Moore L.B.
,
Collins J.L.
,
Oplinger J.A.
,
Kliewer S.A.
,
Gampe R.T. Jr.
,
McKee D.D.
,
Moore J.T.
,
Willson T.M.
Proc. Natl. Acad. Sci. U.S.A.98:13919-13924(2001)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 192-468 IN COMPLEX WITH SYNTHETIC AGONIST
22.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.24 ANGSTROMS) OF 196-468 IN COMPLEX WITH SYNTHETIC AGONIST
23.
"Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha."
Xu H.E.
,
Stanley T.B.
,
Montana V.G.
,
Lambert M.H.
,
Shearer B.G.
,
Cobb J.E.
,
McKee D.D.
,
Galardi C.M.
,
Plunket K.D.
,
Nolte R.T.
,
Parks D.J.
,
Moore J.T.
,
Kliewer S.A.
,
Willson T.M.
,
Stimmel J.B.
Nature415:813-817(2002)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 200-468 IN COMPLEX WITH SYNTHETIC AGONIST
24.
"Design and synthesis of oxime ethers of alpha-acyl-beta-phenylpropanoic acids as PPAR dual agonists."
Oon Han H.
,
Kim S.H.
,
Kim K.-H.
,
Hur G.-C.
,
Joo Yim H.
,
Chung H.-K.
,
Ho Woo S.
,
Dong Koo K.
,
Lee C.-S.
,
Sung Koh J.
,
Kim G.T.
Bioorg. Med. Chem. Lett.17:937-941(2007)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 199-468 IN COMPLEX WITH SYNTHETIC AGONIST
25.
"Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agents."
Sierra M.L.
,
Beneton V.
,
Boullay A.-B.
,
Boyer T.
,
Brewster A.G.
,
Donche F.
,
Forest M.-C.
,
Fouchet M.-H.
,
Gellibert F.J.
,
Grillot D.A.
,
Lambert M.H.
,
Laroze A.
,
Le Grumelec C.
,
Linget J.M.
,
Montana V.G.
,
Nguyen V.-L.
,
Nicodeme E.
,
Patel V.
,
Penfornis A.
,
Pineau O.
,
Pohin D.
,
Potvain F.
,
Poulain G.
,
Ruault C.B.
,
Saunders M.
,
Toum J.
,
Xu H.E.
,
Xu R.X.
,
Pianetti P.M.
more...
J. Med. Chem.50:685-695(2007)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 202-468 IN COMPLEX WITH SYNTHETIC AGONIST
26.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF 200-468 IN COMPLEX WITH THE SYNTHETIC AGONIST TIPP-703
27.
"Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes."
Benardeau A.
,
Benz J.
,
Binggeli A.
,
Blum D.
,
Boehringer M.
,
Grether U.
,
Hilpert H.
,
Kuhn B.
,
Maerki H.P.
,
Meyer M.
,
Puentener K.
,
Raab S.
,
Ruf A.
,
Schlatter D.
,
Mohr P.
Bioorg. Med. Chem. Lett.19:2468-2473(2009)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 199-468 IN COMPLEX WITH ALEGLITAZAR
28.
"Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent."
Artis D.R.
,
Lin J.J.
,
Zhang C.
,
Wang W.
,
Mehra U.
,
Perreault M.
,
Erbe D.
,
Krupka H.I.
,
England B.P.
,
Arnold J.
,
Plotnikov A.N.
,
Marimuthu A.
,
Nguyen H.
,
Will S.
,
Signaevsky M.
,
Kral J.
,
Cantwell J.
,
Settachatgull C.
,
Yan D.S.
,
Fong D.
,
Oh A.
,
Shi S.
,
Womack P.
,
Powell B.
,
Habets G.
,
West B.L.
,
Zhang K.Y.J.
,
Milburn M.V.
,
Vlasuk G.P.
,
Hirth K.P.
,
Nolop K.
,
Bollag G.
,
Ibrahim P.N.
,
Tobin J.F.
more...
Proc. Natl. Acad. Sci. U.S.A.106:262-267(2009)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 199-468 IN COMPLEX WITH INDEGLITAZAR